20 December 2021 This is an important announcement for our community engaged in fighting liver cancer and viral hepatitis. Given the current and evolving constraints and uncertainty triggered by COVID-19, the EASL Governing Board has decided that two events scheduled…
20 December 2021 On 22 November 2021, EASL held its annual Patient Forum on the topic: health literacy to empower patients and address inequities. We collaborated with five members of our Patient Synergies network to bring together the expertise of…
The EASL–Lancet Liver Commission calls for a paradigm shift in the liver disease response in Europe: prevention and early detection, not end-stage treatment of complications. Liver disease is now the second leading cause of years of working life lost in…
9 November 2021 With October being a month dedicated to promoting liver cancer awareness, EASL participated in numerous relevant activities. EASL leadership played a key role notably in two high-level advocacy events, coming to the heart of advocacy. The European…
Are you passionate about social media and scientific communication? Do you have a flair for starting online conversations? Does the idea of discussing your field of research with the world wide web delight you? If the mantra "like, share, comment"…
EASL’s engagement with nurses and Allied Health Professionals (AHPs) has been thriving through 2021. Their next contribution for the global liver community is a webinar by the EASL Nurses and AHPs Task Force in which they will be sharing their expertise on managing NAFLD in patients. …
EASL’s International Liver Congress™ (ILC) 2022 will be taking place in London, UK, 22–26 June 2022. Delegates can attend in person or remotely. This first-in-class, international event is running for the 57th time and is the largest annual event on…
Together with 21 international medical societies EASL strongly reaffirms the essential values held by the global community of transplant providers. We stand against any form of barriers in access, knowledge, transition and required training around organ donation. We back the…
17 September 2021 On 14 September 2021, EASL, in its role as non-state actor in official relations with the World Health Organization (WHO), provided a joint statement on matters of considerable importance in liver care: primary health care and keeping viral hepatitis elimination clearly on the agenda.
15 September 2021 It is with great sadness that EASL announces the passing of Prof. Peter L.M. Jansen, devoted to cholestatic and metabolic liver disease, a longstanding member of the EASL community, and an inspiration to the hepatology community. We…